Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Stuchbery

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2016
Molecular Pathways: Targeting DNA Repair Pathway Defects Enriched in MetastasisNiall M Corcoran, Michael J Clarkson, Ryan Stuchbery, et al.
Nature Reviews. Urology|November 9, 2016
Androgen synthesis in prostate cancer: do all roads lead to Rome?Ryan Stuchbery, Patrick J McCoy, Christopher M Hovens, et al.
World Journal of Urology|November 2, 2018
Developments in oligometastatic hormone-sensitive prostate cancerKen Chow, Patrick McCoy, Ryan Stuchbery, et al.
BJU International|September 25, 2018
Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progressionKen Chow, Pia Herrera, Ryan Stuchbery, et al.
Endocrine Connections|April 9, 2019
Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fatStefano Mangiola, Ryan Stuchbery, Patrick McCoy, et al.
Oncotarget|April 28, 2016
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progressionRyan Stuchbery, Geoff Macintyre, Marek Cmero, et al.
Current Cancer Drug Targets|April 18, 2015
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate CancerRyan Stuchbery, Natalie J Kurganovs, Patrick J McCoy, et al.
Endocrine-Related Cancer|March 30, 2018
Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancerStefano Mangiola, Ryan Stuchbery, Geoff Macintyre, et al.
Brain : a Journal of Neurology|March 16, 2015
Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injurySandy R Shultz, David K Wright, Ping Zheng, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2021
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancerPatrick McCoy, Stefano Mangiola, Geoff Macintyre, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2016
Molecular Pathways: Targeting DNA Repair Pathway Defects Enriched in MetastasisNiall M Corcoran, Michael J Clarkson, Ryan Stuchbery, et al.
Nature Reviews. Urology|November 9, 2016
Androgen synthesis in prostate cancer: do all roads lead to Rome?Ryan Stuchbery, Patrick J McCoy, Christopher M Hovens, et al.
World Journal of Urology|November 2, 2018
Developments in oligometastatic hormone-sensitive prostate cancerKen Chow, Patrick McCoy, Ryan Stuchbery, et al.
BJU International|September 25, 2018
Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progressionKen Chow, Pia Herrera, Ryan Stuchbery, et al.
Endocrine Connections|April 9, 2019
Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fatStefano Mangiola, Ryan Stuchbery, Patrick McCoy, et al.
Oncotarget|April 28, 2016
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progressionRyan Stuchbery, Geoff Macintyre, Marek Cmero, et al.
Current Cancer Drug Targets|April 18, 2015
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate CancerRyan Stuchbery, Natalie J Kurganovs, Patrick J McCoy, et al.
Endocrine-Related Cancer|March 30, 2018
Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancerStefano Mangiola, Ryan Stuchbery, Geoff Macintyre, et al.
Brain : a Journal of Neurology|March 16, 2015
Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injurySandy R Shultz, David K Wright, Ping Zheng, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2021
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancerPatrick McCoy, Stefano Mangiola, Geoff Macintyre, et al.
Pageof 2